Generated by GPT-5-mini| Society for Women's Health Research | |
|---|---|
| Name | Society for Women's Health Research |
| Abbreviation | SWHR |
| Formation | 1990 |
| Type | Nonprofit organization |
| Headquarters | Washington, D.C. |
| Region served | United States |
| Leader title | President and CEO |
Society for Women's Health Research is an American nonprofit advocacy organization focused on sex and gender differences in biomedical research and clinical practice. It engages with policymakers, academic institutions, health systems, and professional societies to advance research on women's health, influence public policy, and translate findings into practice. The organization collaborates with federal agencies, private foundations, and medical societies to promote equity in research funding and clinical care.
Founded in 1990, the organization emerged amid advocacy movements for women's representation in clinical trials after campaigns by groups associated with National Institutes of Health, U.S. Congress, Office of Research on Women's Health, and activists connected to the Women's Health Movement. Early interactions involved stakeholders from Harvard Medical School, Johns Hopkins University, Mayo Clinic, and policy advisors from Gingrich era Washington. Throughout the 1990s and 2000s it worked alongside entities such as National Academy of Medicine, Food and Drug Administration, Centers for Disease Control and Prevention, and members of United States Senate committees to highlight sex-based differences in cardiovascular disease research following landmark studies by investigators at Columbia University, Brigham and Women's Hospital, and Cedars-Sinai Medical Center. The group expanded programming during the 2010s to align with initiatives by European Medicines Agency, World Health Organization, and advocacy by organizations linked to American Heart Association and American College of Cardiology.
The stated mission centers on improving health outcomes for women through science, policy, and education, aligning priorities with bodies such as National Institute of Mental Health, National Heart, Lung, and Blood Institute, Patient Protection and Affordable Care Act stakeholders, and clinical guideline committees from American College of Obstetricians and Gynecologists. Key objectives include accelerating sex-specific biomedical research in collaboration with networks tied to Howard University, University of California, San Francisco, Yale University, and ensuring implementation in care settings influenced by Veterans Health Administration and large health systems like Kaiser Permanente.
Programs have included research networks, training fellowships, and task forces that partner with academic hubs such as Stanford University, University of Pennsylvania, University of Michigan, and specialty societies including American College of Physicians and Endocrine Society. Initiative themes cover cardiovascular health with input from American Heart Association councils, autoimmune disease informed by investigators at Johns Hopkins University School of Medicine, and brain health aligning with research centers at Massachusetts General Hospital and Mount Sinai Health System. Pilot projects have tied into consortia affiliated with All of Us Research Program and precision medicine efforts connected to National Human Genome Research Institute.
The organization has contributed to legislative and regulatory shifts by briefing members of United States Congress, submitting comments to Food and Drug Administration, and collaborating with task forces at National Academy of Medicine and Institute of Medicine. Its advocacy influenced increased inclusion criteria reforms at National Institutes of Health and informed guidance used by specialty panels convened by American Diabetes Association and American Psychiatric Association. Research white papers and consensus statements produced with partners from Columbia University Irving Medical Center, University of California, Los Angeles, and Northwestern University have shaped clinical trial design and spurred funding calls at agencies such as National Institute on Aging and National Cancer Institute.
Outreach efforts include public education campaigns, professional symposia, and patient-facing materials developed with collaborators like National Women's Law Center, Susan G. Komen for the Cure, and academic medical centers including Duke University School of Medicine and University of Texas MD Anderson Cancer Center. Annual conferences convene clinicians and researchers from institutions such as Cleveland Clinic and Vanderbilt University Medical Center and often feature panels with representatives from World Health Organization regional offices, leaders from American Medical Association, and experts connected to Johns Hopkins Bloomberg School of Public Health.
Funding sources have included grants and contracts from federal agencies like National Institutes of Health, philanthropic support from foundations such as Robert Wood Johnson Foundation and Gordon and Betty Moore Foundation, and corporate partnerships with health industry stakeholders including firms represented at BIO International Convention and associations like PhRMA. Collaborations span university research centers at Brown University, Emory University, and think tanks including Kaiser Family Foundation.
Governance comprises a board of directors and scientific advisory council with leaders drawn from academic institutions including Columbia University, Yale School of Medicine, Harvard T.H. Chan School of Public Health, and clinical leaders associated with Brigham and Women's Hospital. Executive leadership has engaged with federal advisory committees such as panels convened by Office of the Surgeon General and experts who have held roles at National Institutes of Health centers and professional societies like Society for Endocrinology and American College of Cardiology.
Category:Medical and health organizations based in the United States